170 related articles for article (PubMed ID: 30680866)
1. Trans-counseling: A case series of transgender individuals at high risk for BRCA1 pathogenic variants.
Sacca RE; Koeller DR; Rana HQ; Garber JE; Morganstern DE
J Genet Couns; 2019 Jun; 28(3):708-716. PubMed ID: 30680866
[TBL] [Abstract][Full Text] [Related]
2. Cancer genetic counselors' experiences with transgender patients: A qualitative study.
Zayhowski K; Park J; Boehmer U; Gabriel C; Berro T; Campion M
J Genet Couns; 2019 Jun; 28(3):641-653. PubMed ID: 30720922
[TBL] [Abstract][Full Text] [Related]
3. Genetic counselors' comfort and knowledge of cancer risk assessment for transgender patients.
Berro T; Zayhowski K; Field T; Channaoui N; Sotelo J
J Genet Couns; 2020 Jun; 29(3):342-351. PubMed ID: 31562693
[TBL] [Abstract][Full Text] [Related]
4. Unanswered Questions: Hereditary breast and gynecological cancer risk assessment in transgender adolescents and young adults.
Sutherland N; Espinel W; Grotzke M; Colonna S
J Genet Couns; 2020 Aug; 29(4):625-633. PubMed ID: 32304336
[TBL] [Abstract][Full Text] [Related]
5. Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-result.
Vos J; Gómez-García E; Oosterwijk JC; Menko FH; Stoel RD; van Asperen CJ; Jansen AM; Stiggelbout AM; Tibben A
Psychooncology; 2012 Jan; 21(1):29-42. PubMed ID: 21072753
[TBL] [Abstract][Full Text] [Related]
6. Transgender patients' perspectives on their cancer genetic counseling experiences.
Rolle L; Zayhowski K; Koeller D; Chiluiza D; Carmichael N
J Genet Couns; 2022 Jun; 31(3):781-791. PubMed ID: 34964220
[TBL] [Abstract][Full Text] [Related]
7. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
; Owens DK; Davidson KW; Krist AH; Barry MJ; Cabana M; Caughey AB; Doubeni CA; Epling JW; Kubik M; Landefeld CS; Mangione CM; Pbert L; Silverstein M; Simon MA; Tseng CW; Wong JB
JAMA; 2019 Aug; 322(7):652-665. PubMed ID: 31429903
[TBL] [Abstract][Full Text] [Related]
8. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Nelson HD; Pappas M; Cantor A; Haney E; Holmes R
JAMA; 2019 Aug; 322(7):666-685. PubMed ID: 31429902
[TBL] [Abstract][Full Text] [Related]
9. Trans-inclusive genetic counseling services: Recommendations from members of the transgender and non-binary community.
Barnes H; Morris E; Austin J
J Genet Couns; 2020 Jun; 29(3):423-434. PubMed ID: 31710150
[TBL] [Abstract][Full Text] [Related]
10. Hormonal and surgical treatment in trans-women with BRCA1 mutations: a controversial topic.
Colebunders B; T'Sjoen G; Weyers S; Monstrey S
J Sex Med; 2014 Oct; 11(10):2496-9. PubMed ID: 25042481
[TBL] [Abstract][Full Text] [Related]
11. "I Don't Want to Be an Ostrich": Managing Mothers' Uncertainty during BRCA1/2 Genetic Counseling.
Fisher CL; Roccotagliata T; Rising CJ; Kissane DW; Glogowski EA; Bylund CL
J Genet Couns; 2017 Jun; 26(3):455-468. PubMed ID: 27473644
[TBL] [Abstract][Full Text] [Related]
12. Surgical and financial implications of genetic counseling and requests for concurrent prophylactic mastectomy.
Murphy RX; Adkinson JM; Namey T; Eid S; Bleznak A
Ann Plast Surg; 2010 May; 64(5):684-7. PubMed ID: 20395792
[TBL] [Abstract][Full Text] [Related]
13. When to Consider Risk-Reducing Mastectomy in BRCA1/BRCA2 Mutation Carriers with Advanced Stage Ovarian Cancer: a Case Study Illustrating the Genetic Counseling Challenges.
Speight B; Tischkowitz M
J Genet Couns; 2017 Dec; 26(6):1173-1178. PubMed ID: 28780755
[TBL] [Abstract][Full Text] [Related]
14. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
[TBL] [Abstract][Full Text] [Related]
15. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
Lerman C; Biesecker B; Benkendorf JL; Kerner J; Gomez-Caminero A; Hughes C; Reed MM
J Natl Cancer Inst; 1997 Jan; 89(2):148-57. PubMed ID: 8998184
[TBL] [Abstract][Full Text] [Related]
16. Quality of life after contralateral prophylactic mastectomy in newly diagnosed high-risk breast cancer patients who underwent BRCA1/2 gene testing.
Tercyak KP; Peshkin BN; Brogan BM; DeMarco T; Pennanen MF; Willey SC; Magnant CM; Rogers S; Isaacs C; Schwartz MD
J Clin Oncol; 2007 Jan; 25(3):285-91. PubMed ID: 17159191
[TBL] [Abstract][Full Text] [Related]
17. Moral concerns of different types of patients in clinical BRCA1/2 gene mutation testing.
Goelen G; Rigo A; Bonduelle M; De Grève J
J Clin Oncol; 1999 May; 17(5):1595-600. PubMed ID: 10334549
[TBL] [Abstract][Full Text] [Related]
18. Genetic counselors' experiences with transgender individuals in prenatal and preconception settings.
Ruderman M; Berro T; Torrey Sosa L; Zayhowski K
J Genet Couns; 2021 Aug; 30(4):1105-1118. PubMed ID: 33599075
[TBL] [Abstract][Full Text] [Related]
19. A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families.
Donenberg T; George S; Ali J; Bravo G; Hernandez K; Sookar N; Ashing KT; Narod SA; Akbari MR; Hurley J
Breast Cancer Res Treat; 2019 Apr; 174(2):469-477. PubMed ID: 30515680
[TBL] [Abstract][Full Text] [Related]
20. Improving gender-affirming care in genetic counseling: Using educational tools that amplify transgender and/or gender non-binary community voices.
Huser N; Hulswit BB; Koeller DR; Yashar BM
J Genet Couns; 2022 Oct; 31(5):1102-1112. PubMed ID: 35460542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
